| Name | Cvs Pharmacy #02301 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 3 Jacobstown Rd, New Egypt, New Jersey 08533 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (609) 758-5103 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
Kaiser Permanente, one of the nation's largest nonprofit health insurance plans, made a big push a few years ago to get its southern California doctors to ask patients about exercise.
Following recent discoveries by its researchers that could significantly change the diagnosis and treatment of a number of diseases, the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine has established the Biomarker Discovery Center on its Stratford campus.
In this Kaiser Health News short take, staff writer Mary Agnes Carey reports: "Health and Human Services Secretary Kathleen Sebelius said Tuesday that "within a couple months we will have a very robust call center operation" to answer consumers' questions about the new health overhaul law" (Kaiser Health News).
In her advocacy for effective disease prevention and health promotion programs, U.S. Surgeon General Regina M. Benjamin, M.D., joined the Southeast Michigan Beacon Community (SEMBC) today to launch the "Fighting D in the D" campaign during a kickoff event, attended by over 225 guests, at the Westin Book Cadillac in downtown Detroit.
› Verified 3 days ago
| NPI Number | 1407948003 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY 02301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3 Jacobstown Rd, New Egypt, NJ 08533 |
| Phone Number | 609-758-5103 |
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
Kaiser Permanente, one of the nation's largest nonprofit health insurance plans, made a big push a few years ago to get its southern California doctors to ask patients about exercise.
Following recent discoveries by its researchers that could significantly change the diagnosis and treatment of a number of diseases, the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine has established the Biomarker Discovery Center on its Stratford campus.
In this Kaiser Health News short take, staff writer Mary Agnes Carey reports: "Health and Human Services Secretary Kathleen Sebelius said Tuesday that "within a couple months we will have a very robust call center operation" to answer consumers' questions about the new health overhaul law" (Kaiser Health News).
In her advocacy for effective disease prevention and health promotion programs, U.S. Surgeon General Regina M. Benjamin, M.D., joined the Southeast Michigan Beacon Community (SEMBC) today to launch the "Fighting D in the D" campaign during a kickoff event, attended by over 225 guests, at the Westin Book Cadillac in downtown Detroit.
› Verified 3 days ago
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
Kaiser Permanente, one of the nation's largest nonprofit health insurance plans, made a big push a few years ago to get its southern California doctors to ask patients about exercise.
Following recent discoveries by its researchers that could significantly change the diagnosis and treatment of a number of diseases, the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine has established the Biomarker Discovery Center on its Stratford campus.
In this Kaiser Health News short take, staff writer Mary Agnes Carey reports: "Health and Human Services Secretary Kathleen Sebelius said Tuesday that "within a couple months we will have a very robust call center operation" to answer consumers' questions about the new health overhaul law" (Kaiser Health News).
In her advocacy for effective disease prevention and health promotion programs, U.S. Surgeon General Regina M. Benjamin, M.D., joined the Southeast Michigan Beacon Community (SEMBC) today to launch the "Fighting D in the D" campaign during a kickoff event, attended by over 225 guests, at the Westin Book Cadillac in downtown Detroit.
› Verified 3 days ago
Cvs Pharmacy #02301 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3 Jacobstown Rd, New Egypt, New Jersey 08533 Phone: (609) 758-5103 | |
Plumsted Apothecary Inc. Type: Community/Retail Pharmacy Location: 28 Brindletown Rd, New Egypt, New Jersey 08533 Phone: (609) 758-8829 |